In this study, SST was also able to prevent neuronal cell death and to reduce production of TNF-α, IL-1β, PGE2, and ROS by the substantia nigra [153], all of which are known to be produced by activated microglial cells in models of PD [154]. This evidence concerns the gene TNF and Parkinson disease.